By using the MethSurv database, a total of 20 methylated CpG sites of MAP3K14 were identified, we further explored the potential mechanism of MAP3K14 up-regulation in HCC and found that DNA hypomethylation in the promoter region of MAP3K14 may lead to its increased expression in HCC. Here, MAP3K14 is linked to hepatocellular carcinoma.